Shares of multi-specialty telehealth platform, Hims & Hers Health, Inc. (HIMS) are rising more than 19% Tuesday morning after reporting nearly 100% revenue growth in the third quarter. Fourth-quarter as well as full-year revenue outlook came in above analysts' view.
Quarterly revenue increased 95% year-over-year to $144.8 million.
The company, however, reported a loss of 18.84 million or $0.09 per share for the third quarter, wider than 15.9 million or $0.08 per share last year, on higher expenses. Analysts on average were expecting a loss of $0.10 per share.
For the fourth quarter, Hims & Hers Health expects revenue to be in the range of $159 million to $162 million. The consensus estimate stands at $134.3 million.
For the full year, revenue is expected between $519 million and $522 million. Analysts expect revenue of $479.9 million for the year.
HIMS, currently at $5.50, has traded in the range of $2.72-$8.63 in the last 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.